SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Hikal Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
524735 INE475B01022 96.8412723 HIKAL 0.32 3,117.04 304.58 0.83 2
Quarters :
ParticularsSep 2025(Rs.Cr)Jun 2025(Rs.Cr)Mar 2025(Rs.Cr)
Gross Sales316.20371.30550.00
Other Operating Income2.309.102.40
Other Income 1.901.000.50
Total Income320.40381.40552.90
Total Expenditure 311.10355.60428.90
PBIDT9.3025.80124.00
Interest 14.9017.1017.90
PBDT-5.608.70106.10
Depreciation41.2039.4037.70
Tax0.000.0017.30
Fringe Benefit Tax0.000.000.00
Deferred Tax-12.10-8.000.80
Reported Profit After Tax-34.70-22.7050.30
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item-34.70-22.7050.30
    
EPS (Unit Curr.)-2.81-1.844.08
EPS (Adj) (Unit Curr.)-2.81-1.844.08
Calculated EPS (Unit Curr.)-2.81-1.844.07
Calculated EPS (Adj) (Unit Curr.)-2.81-1.844.07
Calculated EPS (Ann.) (Unit Curr.)-11.24-7.3516.29
Calculated EPS (Adj) (Ann.) (Unit Curr.)-11.24-7.3516.29
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity24.7024.7024.70
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)2.946.9522.55
PBDTM(%)-1.772.3419.29
PATM(%)-10.97-6.119.15